117 related articles for article (PubMed ID: 19041002)
1. Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma.
Yip L; Seethala RR; Nikiforova MN; Nikiforov YE; Ogilvie JB; Carty SE; Yim JH
Surgery; 2008 Dec; 144(6):949-55; discussion 954-5. PubMed ID: 19041002
[TBL] [Abstract][Full Text] [Related]
2. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss in parathyroid neoplasia can help characterize malignancy.
Hunt JL; Carty SE; Yim JH; Murphy J; Barnes L
Am J Surg Pathol; 2005 Aug; 29(8):1049-55. PubMed ID: 16006799
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability and loss of heterozygosity in primary and secondary proliferative lesions of the parathyroid gland.
Koshiishi N; Chong JM; Fukasawa T; Ikeno R; Tanaka A; Kanazawa K; Ogura M; Ebuchi M; Takizawa T; Funata N; Fukayama M
Lab Invest; 1999 Sep; 79(9):1051-8. PubMed ID: 10496523
[TBL] [Abstract][Full Text] [Related]
5. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in gastric neuroendocrine tumor.
Han HS; Kim HS; Woo DK; Kim WH; Kim YI
Anticancer Res; 2000; 20(5A):2849-54. PubMed ID: 11062692
[TBL] [Abstract][Full Text] [Related]
7. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma.
Haven CJ; van Puijenbroek M; Karperien M; Fleuren GJ; Morreau H
J Pathol; 2004 Jan; 202(1):86-94. PubMed ID: 14694525
[TBL] [Abstract][Full Text] [Related]
9. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
Raue F; Haag Ch; Frank-Raue K
Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa.
Ozolek JA; Hunt JL
Am J Surg Pathol; 2006 Dec; 30(12):1576-80. PubMed ID: 17122514
[TBL] [Abstract][Full Text] [Related]
11. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
12. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
Nunes F; Shen Y; Niida Y; Beauchamp R; Stemmer-Rachamimov AO; Ramesh V; Gusella J; MacCollin M
Cancer Genet Cytogenet; 2005 Oct; 162(2):135-9. PubMed ID: 16213361
[TBL] [Abstract][Full Text] [Related]
13. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
Gupta S; Joshi K; Wig JD; Arora SK
Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31.
Xia JC; Weng DS; Li JT; Qin HD; Mai SJ; Feng BJ; Fan Q; Feng QS; Huang LX; Yu XJ; Pan ZZ; Li YQ; Wang QJ; Zhan YQ; Chen SP; He J; Huang WL; Wu PH; Zeng YX
Cancer Genet Cytogenet; 2006 Apr; 166(2):166-72. PubMed ID: 16631475
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid carcinoma.
Mittendorf EA; McHenry CR
J Surg Oncol; 2005 Mar; 89(3):136-42. PubMed ID: 15719375
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas.
Shan L; Yang Q; Nakamura Y; Nakamura M; Miyauchi A; Tsujimoto M; Nakatani Y; Wakasa K; Mori I; Kakudo K
Mod Pathol; 2001 Apr; 14(4):273-8. PubMed ID: 11301342
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
Kanellou P; Zaravinos A; Zioga M; Spandidos DA
Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
[TBL] [Abstract][Full Text] [Related]
18. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
[TBL] [Abstract][Full Text] [Related]
19. Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix.
Maheshwari V; Tsung A; Lin Y; Zeh HJ; Finkelstein SD; Bartlett DL
Ann Surg Oncol; 2006 Dec; 13(12):1610-6. PubMed ID: 17009159
[TBL] [Abstract][Full Text] [Related]
20. Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma.
Shattuck TM; Kim TS; Costa J; Yandell DW; Imanishi Y; Palanisamy N; Gaz RD; Shoback D; Clark OH; Monchik JM; Wierman ME; Hollenberg A; Tojo K; Chaganti RS; Arnold A
Clin Endocrinol (Oxf); 2003 Aug; 59(2):180-9. PubMed ID: 12864795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
